icon-folder.gif   Conference Reports for NATAP  
 
  Digestive Disease Week
02nd - 05th June
2018 Washington, D.C
Back grey_arrow_rt.gif
 
 
 
SOF/VEL/VOX for 12 Weeks is a Safe and Effective Salvage Regimen for NS5A Inhibitor-Experienced Patients with Genotype 1-6 HCV Infection: An Integrated Analysis of Phase 2 and Phase 3 Studies
 
 
  at Digestive Disease Week
02nd - 05th June, 2018 Washington, D.C
 
Eric Lawitz1, Michael P. Manns2, Marc Bourlière3, Nelson Cheinquer4, Luisa M. Stamm4, Rob H. Hyland4, Liyun Ni4, Hadas Dvory-Sobol4, Diana M. Brainard4, G. Mani Subramanian4, Edward J. Gane5
 
1Texas Liver Institute, University of Texas Health San Antonio, San Antonio, TX, USA; 2Hannover Medical School, Hannover, Germany; 3Hopital Saint Joseph, Marseille, France; 4Gilead Sciences, Inc., Foster City, CA, USA; 5Auckland University, Auckland, New Zealand

0618181

0618182

0618183

0618184

0618185

0618186

0618187